{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:04:58Z","timestamp":1782979498745,"version":"3.54.5"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> The first year of the COVID-19 pandemic has been highly disruptive for people with cancer. Furthermore, it has been shown that accrual to cancer trials dropped substantially in 2020. Building on findings from a previous pilot survey, the present study used qualitative methods to gain insights into attitudes towards participation in research studies amongst people who have experienced cancer, in the context of the first year of the COVID-19 pandemic.<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> We interviewed 13 participants from the UK, who were purposively sampled, including a broad sample of cancer types, and a mixture of individuals who have and have not taken part in research previously. Participants underwent semi-structured interviews (median interview duration: 47 min) and were asked open-ended questions about their attitude towards and experiences with COVID-19, and their attitude towards research participation. In addition to this, prompts were used to ask participants about concerns that were highlighted by our previous quantitative work on this topic, such as concerns about being older or having to travel to participate. Interview transcripts were analysed using a framework analysis approach.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our findings suggest that cancer patient decision-making about research participation during an infectious disease pandemic may be a function of a basic cost-benefit analysis, which considers the benefit of taking part, either personally to themselves or to wider society. The benefit may then be weighed by the patient against the risk of being infected, which may be influenced by trust in the relevant clinicians\/researchers; familiarity with the study location; provision of detailed information on safety protocols for infectious disease; and, in particular, the availability of safe transport to and from the study location.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> Some cancer patients say that they would be less likely to participate in a research study in the middle of an infectious disease pandemic due to an increased risk to themselves. Patients' perceived risk to themselves from participating may be ameliorated <jats:italic>via<\/jats:italic> the provision of certain practical solutions that can be considered at the study protocol design stage, such as safe travel, information, and the use of staff and study sites familiar to the patient.<\/jats:p>","DOI":"10.3389\/fpubh.2021.741188","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T05:27:42Z","timestamp":1635485262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["\u201cSomething Good Has to Come Out of the Horror\u201d: A Qualitative Examination of Cancer Survivors' Attitudes Towards Participation in Research During the First Year of the COVID-19 Pandemic"],"prefix":"10.3389","volume":"9","author":[{"given":"Louis","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Wylie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Haire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saran","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Kibaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Van Hemelrijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"B1","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed."},{"key":"B2","unstructured":"GenevaWorld Health OrganizationMaintaining Essential Health Services: Operational Guidance for the COVID-19 Context Interim Guidance.2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e043590","DOI":"10.1136\/bmjopen-2020-043590","article-title":"Impact on health and provision of healthcare services during the COVID-19 lockdown in India: a multicentre cross-sectional study","volume":"11","author":"Raman","year":"2021","journal-title":"BMJ Open"},{"key":"B4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/hpm.3067","article-title":"Impact of COVID-19 on access to healthcare in low- and middle-income countries: current evidence and future recommendations","volume":"36","author":"Okereke","year":"2021","journal-title":"Int J Health Plan Manag"},{"key":"B5","doi-asserted-by":"publisher","first-page":"m1172","DOI":"10.1136\/bmj.m1172","article-title":"Clinical trials suspended in UK to prioritise covid-19 studies and free up staff","volume":"368","author":"Thornton","year":"2020","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2010651","DOI":"10.1001\/jamanetworkopen.2020.10651","article-title":"Association of the coronavirus disease 2019 (COVID-19) outbreak with enrollment in cancer clinical trials","volume":"3","author":"Unger","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa144","article-title":"The impact of COVID-19 on clinical trial execution at the Dana-Farber Cancer Institute","author":"Tolaney","year":"2020","journal-title":"J Natl Cancer Inst."},{"key":"B8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jamaoncol.2020.5748","article-title":"Association of the COVID-19 outbreak with patient willingness to enroll in cancer clinical trials","volume":"7","author":"Fleury","year":"2021","journal-title":"JAMA Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1073274821989315","DOI":"10.1177\/1073274821989315","article-title":"Gender differences in concerns about participating in cancer research during the COVID-19 pandemic","volume":"28","author":"Fox","year":"2021","journal-title":"Cancer Control"},{"key":"B10","first-page":"38","article-title":"Consequences of the COVID-19 pandemic on cancer clinical trials","volume":"4","author":"Flores","year":"2021","journal-title":"Cancer Med J"},{"key":"B11","volume-title":"National Cancer Research Institute (NCRI)","year":"2020"},{"key":"B12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1158\/1078-0432.CCR-20-3421","article-title":"Similarities in risk for COVID-19 and cancer disparities","volume":"27","author":"Newman","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/wmh3.370","article-title":"Social determinants and COVID-19 disparities: differential pandemic effects and dynamics","volume":"12","author":"McNeely","year":"2020","journal-title":"World Med Health Policy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1470-2045(06)70576-9","article-title":"Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors","volume":"7","author":"Mills","year":"2006","journal-title":"Lancet Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2147\/JMDH.S266281","article-title":"Deciding to enrol in a cancer trial: a systematic review of qualitative studies","volume":"13","author":"Viljoen","year":"2020","journal-title":"J Multidiscipl Healthcare"},{"key":"B16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3322\/caac.21638","article-title":"Older adult participation in cancer clinical trials: a systematic review of barriers and interventions","volume":"71","author":"Sedrak","year":"2021","journal-title":"Cancer J Clin"},{"key":"B17","doi-asserted-by":"publisher","first-page":"E387","DOI":"10.1188\/10.ONF.E387-E399","article-title":"Decision making for cancer clinical trial participation: a systematic review","volume":"37","author":"Biedrzycki","year":"2010","journal-title":"Oncol Nurs Forum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/jnci\/djaa155","article-title":"When offered to participate: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials","volume":"113","author":"Unger","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"B19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1177\/1090198117727324","article-title":"You have to approach us right: a qualitative framework analysis for recruiting African Americans into mHealth research","volume":"44","author":"James","year":"2017","journal-title":"Health Educ Behav."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1177\/0269215520930796","article-title":"Recruitment challenges in stroke rehabilitation randomized controlled trials: a qualitative exploration of trialists' perspectives using framework analysis","volume":"34","author":"McGill","year":"2020","journal-title":"Clin Rehabil"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.4324\/9780203413081_chapter_9","article-title":"Qualitative data analysis for applied policy research.","volume-title":"Analyzing Qualitative Data.","author":"Ritchie","year":"1994"},{"key":"B23","doi-asserted-by":"publisher","first-page":"13978","DOI":"10.1038\/s41598-018-32264-x","article-title":"Analysis of racial\/ethnic representation in select basic and applied cancer research studies","volume":"8","author":"Guerrero","year":"2018","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/bjc.2014.108","article-title":"The impact of socioeconomic status on access to cancer clinical trials","volume":"111","author":"Sharrocks","year":"2014","journal-title":"Br J Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1002\/cncr.32989","article-title":"Residential segregation and overall survival of women with epithelial ovarian cancer","volume":"126","author":"Westrick","year":"2020","journal-title":"Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.annepidem.2007.12.006","article-title":"The impact of different measures of socioeconomic position on the relationship between ethnicity and health","volume":"18","author":"Kelaher","year":"2008","journal-title":"Ann Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12885-015-1628-8","article-title":"Exploring research participation among cancer patients: analysis of a national survey and an in-depth interview study","volume":"15","author":"McGrath-Lone","year":"2015","journal-title":"BMC Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1353\/hpu.0.0323","article-title":"More than Tuskegee: understanding mistrust about research participation","volume":"21","author":"Scharff","year":"2010","journal-title":"J Health Care Poor Underserved."},{"key":"B29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12687-014-0186-0","article-title":"Engaging diverse populations about biospecimen donation for cancer research","volume":"5","author":"Dang","year":"2014","journal-title":"J Commun Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/cncr.31168","article-title":"MS. Time, trust, and transparency: lessons learned from collecting blood biospecimens for cancer research from the Asian American community","volume":"124","author":"Dang","year":"2018","journal-title":"Cancer"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.741188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T05:27:49Z","timestamp":1635485269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2021.741188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":30,"alternative-id":["10.3389\/fpubh.2021.741188"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2021.741188","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"article-number":"741188"}}